It seems like the Biotech sector has become the can’t miss sector of 2015, everything I read and hear is bullish, and probably rightfully so.  Many of the big cap biotechs make a ton of money and have fantastic pipelines. However, stocks/sectors go up AND down not up OR down, and it seems to me that many believe that biotech is now a one way street, up. The biotech sector without a doubt has reached the acceptance stage after 5 years and a 360% move (NBI-X), and its probably getting to the euphoric stage.
Allow me to introduce you to $BIS.

ProShares UltraShort Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the NASDAQ Biotechnology Index®.

This will come in handy to those who believe that sectors go up and down not up or down, and will like to possibly take advantage of a POSSIBLE post euphoric (blow off) move.
Zor Capital LLC is a New York based investment management firm, founded in 2011. Our goal is superior performance, with preservation of capital as our number one priority. Zor Capital manages separate accounts (both taxable and retirement) for accredited investors and institutions. This structure gives clients access to a hedge fund like strategy while maintaining 100% control of their accounts.  Managed Assets

The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.
This information is issued solely for informational and educational purposes and does not constitute an offer to sell or a solicitation of an offer to buy securities. None of the information contained in this blog constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. From time to time, the content creator or its affiliates may hold positions or other interests in securities mentioned in this blog. The stocks presented are not to be considered a recommendation to buy any stock. This material does not take into account your particular investment objectives. Investors should consult their own financial or investment adviser before trading or acting upon any information provided. Past performance is not indicative of future results.